EUVIMEDEUVIMED entdecken
Crossref

Closed system production of serum eye drops using dockable saline

Susy Kirwan iD, Patrick S L Kwan iD, Ronald So, Alice Tuinukuafe

Vox Sanguinis · 2023

DOI: 10.1111/vox.13494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2023. Verfasst von Susy Kirwan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Development Team, New Zealand Blood Service, Auckland, New Zealand. Hauptthemen laut MEDLINE: Serum, Drug Contamination. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives A fully closed system solution to manufacture serum eye drops using diluted serum has remained elusive, necessitating production steps to mitigate bacterial contamination risks in a clean suite environment, hampering production efficiency amid growing demand. We describe our recent implementation of a fully closed manufacturing process at New Zealand Blood Service. Materials and Methods A dockable format for sterile saline manufactured to custom specifications configured with a 15‐cm tubing to enable sterile connections was sourced from a local pharmaceutical manufacturer.

Results

From a total of 30,168 eye drop vials manufactured since implementation, the average production time was reduced by up to 45% performed in the general laboratory environment, attributed to eliminating processes performed in a clean suite. No bacterial contamination was observed, demonstrating robust sterile connections.

Conclusion

Dockable saline takes serum eye drops manufactured from a functionally closed system to a fully closed system, thereby enhancing patient safety, significantly reducing manufacturing time and cost and transforming production from a highly restrictive process into a portable workflow that is simple, practical and effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SerumDrug ContaminationHumansOphthalmic SolutionsNew Zealand

Stichwörter der Autor:innen

bacterial contaminationclosed systemdockable salineocular surface diseasepatient safetyserum eye drops

Substanzen

Ophthalmic Solutions

Autor:innen und Institutionen

  • Clinical Development Team, New Zealand Blood Service, Auckland, New Zealand.
  • Cellular and Tissue Laboratory, New Zealand Blood Service, Auckland, New Zealand.

ORCID-Profile: Susy Kirwan, Patrick S L Kwan

Zitieren

APA

Kirwan, S., Kwan, P. S. L., So, R., & Tuinukuafe, A. (2023). Closed system production of serum eye drops using dockable saline. Vox Sanguinis. https://doi.org/10.1111/vox.13494

Vancouver

Kirwan S, Kwan PSL, So R, Tuinukuafe A. Closed system production of serum eye drops using dockable saline. Vox Sanguinis. 2023. doi:10.1111/vox.13494

BibTeX
@article{Kirwan2023,
  author = {Kirwan, Susy and Kwan, Patrick S L and So, Ronald and Tuinukuafe, Alice},
  title = {Closed system production of serum eye drops using dockable saline},
  journal = {Vox Sanguinis},
  year = {2023},
  doi = {10.1111/vox.13494}
}
Kostenlos starten →